1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67AE02293CDFDF09E652578160023B7F7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/market-research-future-achieve-balance-between-strategic-tactical-function?opendocument
18
19opendocument
2098.81.24.230
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Building Influence and Enhancing Business Value

The Future of Market Research: Achieving a Balance Between Strategic and Tactical

ID: 5113


Features:

7 Info Graphics

8 Data Graphics

75 Metrics

4 Narratives


Pages/Slides: 22


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "The Future of Market Research: Achieving a Balance Between Strategic and Tactical"

STUDY OVERVIEW

Market research (MR) has always been an important function in the pharmaceutical industry, particularly for providing critical insights related to marketing and brand team support. Over the years, the focus of market research has expanded to more strategically focused areas such as new product planning and strategy. As the market research function has evolved, it has become challenging to balance between the strategic and tactical requirements of the function.

Best Practices, LLC conducted this research to explore how the requirements of the market research function are evolving into a more strategic focus that has a larger impact on the organization's future. Market research leaders can use this research to compare their MR functions current and expected activities with those of other organizations.

KEY TOPICS

  • Role of market research
  • Shift in the role of market research
  • Focus of successful market research program
  • Future of market research

SAMPLE METRICS
  • Percent rating for future level of market research support for other functions/activities
  • Market research responsibility level for variety of key activities
  • Percent rating for current level of market research support for other functions/activities
  • Desired percent mix of strategic vs. tactical market research focus in 3-5 years

SAMPLE KEY FINDING
  • Future of Market Research: In the next three to five years, New Product Development will receive increased support from Market Research. Additionally, Strategy and Business Development will continue to rely on Market Research as a decision support service.

METHODOLOGY

The research employed a data gathering approach that gleaned quantitative data from 42 manager and executives from 34 leading companies in pharmaceutical, biotechnology and medical device industries. In addition, 6 executives participated in in-depth interviews.


Industries Profiled:
Professional Services; Health Care; Pharmaceutical; Diagnostic; Medical Device; Research; Biotech; Technology; Manufacturing; Consumer Products; Media; Consulting; Energy


Companies Profiled:
Adler Life Sciences; LLC; Abbott; Charles River; Auxilium; BioChain; Bayer; Boehringer Ingelheim; Inventiv Health; Alcon; Labopharm; Actelion; IRIS; Bausch & Lomb; Cubist Pharmaceuticals; Cephalon; Inc.; CSL Behring; EMD Serono; GlaxoSmithKline; IDS Canada; Ethicon Endo-Surgery Inc.; Galderma; IMS; Medrad; Orion Energy; MSD; Vertex Pharmaceuticals; Ortho-McNeil; Merck; Novo Nordisk; Pfizer; Vistakon; Johnson & Johnson

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.